31 results
8-K/A
EX-10.1
CHRS
Coherus Biosciences Inc
21 May 24
Financial Statements and Exhibits
5:14pm
written notice that the FDA (or applicable foreign equivalent), any other Governmental Authority or any institutional review board, ethics committee
424B3
CHRS
Coherus Biosciences Inc
26 Jul 23
Prospectus supplement
4:59pm
)
Excluded Shares
2.1(b)
FCPA
FDA
3.21(c)
FDA Ethics Policy
3.21(i)
FDCA
3.21(a)
First Merger
Recitals
Form S-4
5.5(a)
Fractional Share Consideration
S-4/A
cazyp8yf1qnq
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
S-4
uab3v
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
425
sfr7fptg50m665
16 Jun 23
Business combination disclosure
8:08am
425
dg2t9 kowsb
16 Jun 23
Business combination disclosure
7:09am
8-K
EX-2.1
yin8ljzof5hefv2m
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am
8-K
EX-10.1
s6cq9if
7 Jan 22
Coherus BioSciences Secures Credit Financing
8:36am